| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |